Radiopharmaceuticals Market

Asia Pacific Radiopharmaceuticals Market by Products (Diagnostics [SPECT and PET] and Therapeutics [Beta Emitters, Brachytherapy, and Alpha Emitters]), Types (Doppler OCT, Catheter, Handheld, and Tabletop), Applications (Diagnostics [Neurology, Cardiology, Oncology, Lymphoma, and Thyroid] and Therapeutics [Bone Metastasis, Thyroid, Lymphoma, and Endocrine Tumor]), and Geography (India, China, South Korea, Japan, and Rest of Asia Pacific) – Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2384
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 180
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Asia Pacific radiopharmaceuticals market size is projected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the positive results of research report on radiopharmaceuticals and wide use of the method for the treatment of various chronic conditions.

Radiopharmaceuticals Market key takeaways

Radiopharmaceuticals refers to molecular imaging that includes the use of molecules as biomarkers for molecular processes that discovers the progress of a disease. The rapid development of the radiopharmaceutical companies and expansion of the pharmaceutical market in the region present major aspects for the market growth. With the rising cases of various chronic illness and rising awareness among people about the diseases in the region, the diagnostic rates are increasing substantially. This is expected to fuel the demand for PET and SPECT devices. Most of the developing nations in this region are working for the stable and efficient healthcare system. It is a great opportunity for the sale of radiopharmaceutical products that finds vast applications across the length and breadth of the healthcare industry.

A report declared in the JurnalSainsNuklear Malaysian in 2016, more than 75.0% of Tc-99m was used in the medical sector in Malaysia and attempts toward grading up self-manufacturing of radiopharmaceutical was aimed at enhancing the healthcare sector of the region. Another phenomenon attributed to affect market is the increase in the number of healthcare improvement and facilities in care.

Market Trends, Drivers, Restraints, and Opportunities

  • Positive results of research studies on radiopharmaceuticals in the treatment of chronic conditions is expected to boost market growth.
  • Large scale development for molecular imaging and wide investment on use of these molecules as biomarkers are expected to boost the market growth.
  • Rise in the number of healthcare facilities establishment and improvement in healthcare provision are expected to propel the market growth.
  • Advancement in scanning technology is further a key factor to fuel the market growth.
  • High cost of radiopharmaceuticals treatment is expected to slow down the market growth.

Scope of the Report                          

The report on Asia Pacific radiopharmaceuticals market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Asia Pacific Radiopharmaceuticals Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Diagnostics [SPECT and PET] and Therapeutics [Beta Emitters, Brachytherapy, and Alpha Emitters]), Types (Doppler OCT, Catheter, Handheld, and Tabletop), Applications (Diagnostics [Neurology, Cardiology, Oncology, Lymphoma, and Thyroid] and Therapeutics [Bone Metastasis, Thyroid, Lymphoma, Endocrine Tumor])

Geography

India, China, South Korea, Japan, and Rest of Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bayer AG; Nordion, Inc.; GE Healthcare; Bracco Group; and Mallinckrodt Public Limited Company.

 

Market Segment Insights

Diagnostics segment is expected to grow at a rapid pace

Based on products, the Asia Pacific radiopharmaceuticals market is bifurcated into diagnostics and therapeutics. The diagnostics segment is further divided into SPECT and PET while the therapeutics segment is sub-segmented into beta emitters, brachytherapy, and alpha emitters. The diagnostics segment accounted for a key share of the market in 2019 and is expected to grow at a rapid pace owing to diagnostic techniques that provide a better insight into the disease than the traditionally used diagnostic devices. However, the therapeutics segment is anticipated to expand at a substantial growth rate during the forecast period due to lowering prices of the scanning devices and government support.

Catheter segment is projected to expand at a considerable CAGR

On the basis of types, the market is divided into doppler OCT, catheter, handheld, and tabletop. The catheter segment is projected to expand at a considerable CAGR during the forecast period due to advancement in catheter technology. Meanwhile, the handheld segment is anticipated to hold a moderate growth rate during the projected period owing to strict regulation of the radioactive elements and complex manufacturing processes.

Radiopharmaceuticals Market  by Types

Therapeutics segment is expected to grow substantially

Based on applications, the Asia Pacific radiopharmaceuticals market is bifurcated into diagnostics and therapeutics. The diagnostics segment is further categorized as neurology, cardiology, oncology, lymphoma, and thyroid while the therapeutics segment includes bone metastasis, thyroid, lymphoma, and endocrine tumor. The therapeutics segment is expected to grow substantially in the coming years due to large number of adoption rate of therapeutic method among people globally. On the other hand, the diagnostics segment is anticipated to exhibit a moderate growth rate during the forecast period owing to wide adoption of the diagnosis.

Radiopharmaceuticals Market by applications

China is anticipated to constitute a key market share

In terms of geography, the market is classified as India, China, South Korea, Japan, and Rest of Asia Pacific. The market of China accounted for a key share of the market in 2019 and is anticipated to constitute a key market share in the coming years due to large number of population and rising prevalence of chronic diseases in the country. The market of India, however, is anticipated to expand at a rapid pace during the forecast period owing to development of healthcare infrastructure and facilities along with the existing favorable government policies.

Segments

Segments Covered in the Report
The Asia Pacific radiopharmaceuticals market has been segmented on the basis of

Products

  • Diagnostics
    • SPECT
    • PET
  • Therapeutics
    • Beta Emitters
    • Brachytherapy
    • Alpha Emitters

Types

  • Doppler OCT
  • Catheter
  • Handheld
  • Tabletop

Applications

  • Diagnostics
    • Neurology
    • Cardiology
    • Oncology
    • Lymphoma
    • Thyroid
  • Therapeutics
    • Bone Metastasis
    • Thyroid
    • Lymphoma
    • Endocrine Tumor

Geography

  • India
  • China
  • South Korea
  • Japan
  • Rest of Asia Pacific

Key Players

  • Bayer AG
  • Nordion, Inc.
  • GE Healthcare
  • Bracco Group
  • Mallinckrodt Public Limited Company

Competitive Landscape

Key players competing in the Asia Pacific radiopharmaceuticals market are Bayer AG; Nordion, Inc.; GE Healthcare; Bracco Group; and Mallinckrodt Public Limited Company. The main market players are continuously engaged in various business expansion activities such as mergers and acquisitions, research and developments, investments for innovative products, and collaborations. For instance, Nordion, Inc. introduced a new custom dose for TheraSphere, in March 2012.

Radiopharmaceuticals Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Radiopharmaceuticals Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Radiopharmaceuticals Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Radiopharmaceuticals Market - Supply Chain
  4.5. Global Radiopharmaceuticals Market Forecast
     4.5.1. Radiopharmaceuticals Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Radiopharmaceuticals Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Radiopharmaceuticals Market Absolute $ Opportunity
5. Global Radiopharmaceuticals Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Radiopharmaceuticals Market Size and Volume Forecast by Types
     5.3.1. Doppler OCT
     5.3.2. Catheter
     5.3.3. Handheld
     5.3.4. Tabletop
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Radiopharmaceuticals Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Radiopharmaceuticals Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Radiopharmaceuticals Demand Share Forecast, 2019-2026
7. North America Radiopharmaceuticals Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Radiopharmaceuticals Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Radiopharmaceuticals Market Size and Volume Forecast by Types
     7.4.1. Doppler OCT
     7.4.2. Catheter
     7.4.3. Handheld
     7.4.4. Tabletop
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Radiopharmaceuticals Demand Share Forecast, 2019-2026
8. Latin America Radiopharmaceuticals Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Radiopharmaceuticals Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Radiopharmaceuticals Market Size and Volume Forecast by Types
     8.4.1. Doppler OCT
     8.4.2. Catheter
     8.4.3. Handheld
     8.4.4. Tabletop
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Radiopharmaceuticals Demand Share Forecast, 2019-2026
9. Europe Radiopharmaceuticals Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Radiopharmaceuticals Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Radiopharmaceuticals Market Size and Volume Forecast by Types
     9.4.1. Doppler OCT
     9.4.2. Catheter
     9.4.3. Handheld
     9.4.4. Tabletop
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Radiopharmaceuticals Demand Share Forecast, 2019-2026
10. Asia Pacific Radiopharmaceuticals Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Radiopharmaceuticals Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Radiopharmaceuticals Market Size and Volume Forecast by Types
     10.4.1. Doppler OCT
     10.4.2. Catheter
     10.4.3. Handheld
     10.4.4. Tabletop
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Radiopharmaceuticals Demand Share Forecast, 2019-2026
11. Middle East & Africa Radiopharmaceuticals Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Radiopharmaceuticals Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Radiopharmaceuticals Market Size and Volume Forecast by Types
     11.4.1. Doppler OCT
     11.4.2. Catheter
     11.4.3. Handheld
     11.4.4. Tabletop
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Radiopharmaceuticals Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Radiopharmaceuticals Market: Market Share Analysis
  12.2. Radiopharmaceuticals Distributors and Customers
  12.3. Radiopharmaceuticals Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Bayer AG
     12.4.2. Nordion, Inc.
     12.4.3. GE Healthcare
     12.4.4. Bracco Group
     12.4.5. Mallinckrodt Public Limited Company

Segments Covered in the Report
The Asia Pacific radiopharmaceuticals market has been segmented on the basis of

Products

  • Diagnostics
    • SPECT
    • PET
  • Therapeutics
    • Beta Emitters
    • Brachytherapy
    • Alpha Emitters

Types

  • Doppler OCT
  • Catheter
  • Handheld
  • Tabletop

Applications

  • Diagnostics
    • Neurology
    • Cardiology
    • Oncology
    • Lymphoma
    • Thyroid
  • Therapeutics
    • Bone Metastasis
    • Thyroid
    • Lymphoma
    • Endocrine Tumor

Geography

  • India
  • China
  • South Korea
  • Japan
  • Rest of Asia Pacific

Key Players

  • Bayer AG
  • Nordion, Inc.
  • GE Healthcare
  • Bracco Group
  • Mallinckrodt Public Limited Company

Key players competing in the Asia Pacific radiopharmaceuticals market are Bayer AG; Nordion, Inc.; GE Healthcare; Bracco Group; and Mallinckrodt Public Limited Company. The main market players are continuously engaged in various business expansion activities such as mergers and acquisitions, research and developments, investments for innovative products, and collaborations. For instance, Nordion, Inc. introduced a new custom dose for TheraSphere, in March 2012.

Radiopharmaceuticals Market by key players

Buy Report